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Introduction 
In 1972 Walker et al. were the first to use the term 
"inflammatory abdominal aortic aneurysm". ~ They de- 
scribed a distinct form of aneurysm characterised by 
"an unusually thick wall surrounded by extensive 
fibrous adhesions involving adjoining tissues and 
structures making the operative procedure much more 
difficult." These extraordinary clinicopathological 
findings were found in 10% of the aneurysms that 
they described. At that time the view of abdominal 
aortic aneurysms changed, and a separate clinical en- 
tity, the inflammatory aneurysm, was recognized. 
Surgeons agree that the triad O f thickened aneurysm 
wall, extensive perianeurysmal nd retroperitoneal 
fibrosis, and dense adhesions of adjacent abdominal 
organs defines the inflammatory abdominal aortic an- 
eurysm (AAA) (Fig. 1). 2 These criteria are identical to 
the original descriptions by Walker, who described a
"thick, firm, smooth wall of the aneurysm which is 
shiny white in appearance." He also noted the "dense 
fibrosis which extends to involve adjacent structures. "1
Evolution of Understanding 
Inflammatory AAAs were initially thought to rep- 
resent distinct clinical and pathological entities dif- 
ferent from noninflammatory aneurysms, due largely 
to their distinct clinical and intraoperative pre- 
sentations. Their earliest descriptions were likely in 
the urological literature by James and DeWeerd in 
1935 and 1955, respectively, and found to be associated 
with ureteral obstruction secondary to retroperitoneal 
) ~  Thick wall 
Fig. 1. Inflammatory, infrarenal ortic aneurysm with adherent duodenum and ureters. 
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inflammation and thickening. 3'4 Walker stated that "in- 
flammatory aneurysms are a discrete ntity with sig- 
nificant differences from atherosclerotic aneurysms". 1 
Although descriptive in nature, the original reports 
of inflammatory AAAs offered little regarding their 
aetiology. 
Through histological grading of AAAs, Rose and 
Dent began a new way of viewing the inflammatory 
AAA in 1981. Not only did they speculate about the 
aetiology, but for the first time they suggested that 
inflammatory AAAs were not separate ntities but 
merely the "accentuation f the chronic inflammation 
and fibrosis that may be observed in relation to ath- 
erosclerotic (noninflammatory) aneurysms". 5 By dem- 
onstrating that an inflammatory process was present 
in the aneurysm wall in all specimens to varying degrees, 
they observed that no sharp distinction existed be- 
tween the usual atherosclerotic aneurysm and the 
inflammatory aneurysm. Furthermore, they proposed 
that the inflammatory aneurysm was the extreme nd 
of an inflammatory process responsible for both the 
inflammatory and noninflammatory AAA. 
Other surgeons ubsequently demonstrated that a 
chronic inflammatory infiltrate occupying the ad- 
ventitia exists in both atherosclerotic and inflammatory 
AAAs. Pennell and Hollier emphasised that the only 
difference between the noninflammatory and the in- 
flammatory AAA is in the "intensity and extent of the 
inflammatory process, suggesting that they are the 
same disease process, differing only in the progression 
of the inflammation".6 In a similar fashion, Sterpetti has 
described "a gradual passage, in terms of inflammatory 
response, from ordinary atherosclerotic to inflam- 
matory response. "7
Emerging data support this theory and suggest a 
primary inflammatory response to an unknown an- 
tigen present within the aortic wall. This response is 
characterised by aortic-wall infiltrating macrophages, 
T-lymphocytes, and B-lymphocytes that activate pro- 
teolytic activity through the production of cytokines. 8 ~ 
This proteolytic activity leads to increased turnover in 
the matrix proteins, elastin, and collagen. Subsequent 
loss of aortic wall integrity and tensile strength occur 
as an aneurysm forms. This inflammatory process is 
accentuated in certain persons with environmental 
risks (e.g. smoking) or a genetic predisposition. The 
extreme nd of the inflammatory spectrum is reached 
and results in an inflammatory AAA at a relatively 
younger age. 
Investigations are now focused on identifying the 
inducing agent, endogenous or exogenous, of this 
immune response. Efforts to isolate the antigen directly 
from aneurysmal tissue have yielded mixed results. 
Breakdown products of elastin and/or red blood cells, 
as well as oxidized low density lipoproteins, have 
been suggested as endogenous antigens. In addition, 
studies by Tilson using immunoglobulin and amino 
acid sequencing techniques provide evidence that an 
endogenous autoantigen exists in aneurysmal disease, 
which is similar to a microfibril-associated gly- 
coprotein, and raises the question of autoimmunity 
as an important mechanism in the pathogenesis of
aneurysms. 12,~3 
In other attempts to directly isolate the antigen 
directly from aortic tissue, Tanaka et al. published 
evidence that the human herpes virus may play a role 
as an exogenous antigen in the pathogenesis of aortic 
diseases. .4'~5 Using DNA polymerase chain reactions, 
they demonstrated that either the herpes implex virus 
or cytomegalovirus was present more frequently in 
the wall of aneurysms than in normal aortic wall. 
In addition, these viruses were more prevalent in 
inflammatory than noninflammatory AAAs. They hy- 
pothesised that the replicating infections of the cyto- 
megalovirus may cause the formation of inflammatory 
aneurysms. 
Our recent investigations have focused on indirect 
approaches tocharacterising a possible antigen related 
to the pathogenesis of inflammatory AAAs. While 
effecting an immune response, an antigen by nature 
leaves a fingerprint of its basic amino acid structure. 
This fingerprint can be viewed from three different 
vantage points and exists as: (i) the selective interaction 
with specific class II HLA molecules, (ii) the pref- 
erential activation of certain inflammatory cells and 
pathways, and (iii) the selective interaction with certain 
T cell receptors. Our studies have focused on char- 
acterising the first of these antigen fingerprints, its 
interaction with specific class II HLA ~ molecules. 
Through HLA typing of patients with inflammatory 
AAAs, we have demonstrated that patients with in- 
flammatory AAAs possess a genetic risk determinant 
which can be mapped to the HLA region. ~6 Specifically, 
we demonstrated that patients with inflammatory 
AAAs preferentially express a unique configuration 
and electrical charge of an antigen binding pocket of 
the HLA-DR molecule, which may represent a portion 
of the fingerprint left by the responsible antigen. Char- 
acterisation of this fingerprint may allow for pre- 
dictions regarding antigenic epitopes and charged 
composition. 
Also of importance is that our work with in- 
flammatory AAAs has raised the question of tobacco 
as a significant environmental promoter of this disease 
process. We have previously demonstrated that a 
greater percentage of patients with inflammatory 
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Fig. 2. A schematic representing the multifactorial pathogenesis of aneurysm development. The three catagories of risk factors, genetic, 
endothelial, and environmental, may also play a role in the progression from the noninflammatory aneurysm to the inflammatory 
abdominal ortic aneurysm. 
AAAs  were current  smokers than patients wi th  non-  
in f lammatory  AAAs,  I7 and  a subgroup of pat ients 
in our recent s tudy appeared to use tobacco more 
f requent ly  and  mani fest  a more aggressive in- 
f lammatory  response. 16 " 
A l though the unders tand ing  of in f lammatory  AAAs  
has evolved much in the 25 years since they were first 
descr ibed by Walker, their aetiology remains unknown 
and is l ikely mult i factor ial  (Fig. 2). A combinat ion  
of env i ronmenta l /ant igen ic ,  endothel ia l  and  genetic 
factors l ikely act upon  the vessel wal l  and cause an- 
eurysm formation. These same factors may be re- 
sponsible,  in certain persons,  for the deve lopment  
of the in f lammatory  AAA.  Further studies to better 
characterise these factors and  the molecular  and cellu- 
lar mechan isms at p lay in the pathogenesis  of in- 
f lammatory  AAAs  are required. 
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